Real‑World Evidence as Part of Post‑Approval Commitments
Real‑World Evidence as Part of Post‑Approval Commitments Harnessing Real‑World Evidence to Meet Post‑Approval Commitments Introduction: Shifting From Controlled Trials to Real‑World Insights Traditional randomized controlled trials (RCTs) often leave key evidence gaps at approval—especially regarding long-term safety, effectiveness in broader populations, and rare adverse events. Real‑World Evidence (RWE), derived from Real‑World Data (RWD) such as…
Read More “Real‑World Evidence as Part of Post‑Approval Commitments” »